Edgewise Therapeutics Inc...

AI Score

0

Unlock

27.55
2.22 (8.76%)
At close: Jan 14, 2025, 3:59 PM
28.30
2.72%
Pre-market Jan 15, 2025, 07:16 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 1.73M 538.00K 272.00K 185.00K 123.00K
Gross Profit -1.73M -538.00K -272.00K -185.00K -123.00K
Operating Income -114.36M -22.08M -43.22M -17.19M -9.92M
Interest Income 14.19M 2.66M 402.00K 69.00K 219.00K
Pretax Income -100.16M -19.41M -42.81M -17.12M -9.71M
Net Income -100.16M -15.40M -42.14M -17.05M -9.49M
Selling & General & Admin 23.45M 5.47M 11.03M 2.21M 1.30M
Research & Development 89.35M 16.61M 32.19M 14.98M 8.62M
Other Expenses n/a n/a n/a n/a n/a
Operating Expenses 114.36M 22.08M 43.22M 17.19M 9.92M
Interest Expense n/a 4.02M n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 114.36M 22.08M 43.22M 17.19M 9.92M
Income Tax n/a -4.02M -674.00K -69.00K -219.00K
Shares Outstanding (Basic) 63.72M 53.59M 49.50M 49.22M 49.22M
Shares Outstanding (Diluted) 63.72M 53.59M 49.50M 49.22M 49.22M
EPS (Basic) -1.57 -0.29 -0.85 -0.35 -0.19
EPS (Diluted) -1.57 -0.29 -0.85 -0.35 -0.19
EBITDA -112.81M -67.10M -42.94M -17.01M -9.80M
Depreciation & Amortization 1.73M 538.00K 272.00K 185.00K 123.00K